Abstract
Orthogonally protected chiral β-hydroxy-γ-amino acids can be accessed in >100 g quantities from readily available starting materials and reagents in 3–4 steps. These chiral synthons contain two adjacent stereocenters along with suitably protected functional groups (O-TBS, N-Boc) for downstream reactivity. Implementation of two existing aldol technologies allows rapid access to all possible stereoisomers of 1. The guiding principles during reaction optimization were reaction scalability and operational efficiency. Conversion of the amino acids to a variety of chiral building blocks in 1–2 steps demonstrates their synthetic utility.
Keywords: aldol, asymmetric, stereochemistry, γ-amino acid, diversity-oriented
1. Introduction
Chiral β-hydroxy γ-amino acids are a class of non-proteinogenic amino acids present in many important biologically active natural products1 (Figure 1), including pepstatin,2 bistramide A,3 hapalosin4 and the didemnins.5 Of particular interest to us was the utility of β-hydroxy γ-amino acids for diversity-oriented synthesis (DOS) in the context of developing new build/couple/pair pathways.6,7 In the present study, we chose to focus on the synthesis of O-TBS-protected β-hydroxy-γ-amino acids 1a–b (Figure 2), which are low in molecular weight and contain handles for downstream chemistry. Anticipating the need for substantial quantities of the four amino acids for development of a number of DOS pathways, we selected chemical transformations that were scalable, robust, and general in scope. The enantioselective aldol8 reaction fits all three criteria.
Figure 1.
Examples of natural products containing β-hydroxy-γ-amino acids.
Figure 2.
Aldol approach to the full matrix of β-hydroxy-γ-amino acids 1a–b.
2. Results and Discussion
After examining the literature regarding the enantioselective synthesis of chiral γ-amino acids,9 we settled on a chiral oxazolidinone protocol pioneered by Evans for the synthesis of the 1,2-syn aldol10 products 1a and a norephedrine approach developed by Abiko for the 1,2-anti aldol11 products 1b. The commercial availability of both antipodes of each chiral auxiliary (3a–b) in large quantities suggested that access to all stereoisomers of β-hydroxy-γ-amino acid 1 should be possible.
Kato and co-workers had reported the preparation of amino substituted acetaldehyde 212 in two steps from relatively inexpensive 2-methylaminoethanol. Though this protocol was facile and was utilized for our preliminary studies, we replaced the reported Parikh-Doering oxidation with a Swern protocol (Scheme 1).13 The change in oxidation conditions produced a cleaner reaction mixture from which the product could be isolated in 200 g scale and the overall unit cost to produce 2 was also reduced.14 With access to substantial quantities of aldehyde 2 and auxiliaries, we proceeded with the development of the two aldol protocols.
Scheme 1.
Aldehyde preparation and syn-aldol reaction.
Seminal work by Evans and co-workers with propionated chiral oxazolidinones has provided access to many 1,2-syn aldol products in high diastereomeric, and ultimately, enantiomeric excess. Although this procedure has been successfully utilized with a variety of aldehydes, we initially encountered unpredictable results when applying it to the reaction of aldehyde 2 and propionate 3a. In our preliminary experiments, a solution of dibutylboron triflate in dichloromethane (1.0 M) was employed which resulted in variable isolated yields (40–90%) of 4a. As noted by Evans15 and others,16 the purity of the Lewis acid directly impacts the chemical yield, product purity and diastereoselectivity. Examining other commercial sources of the Lewis acid led to a solution of dibutylboron triflate in toluene (1 M),17 which was more stable to prolonged storage.18 Replacing dichloromethane with toluene as the reaction solvent, however, led to slower reaction rates and lower yields. After examining a variety of solvent combinations, we arrived at a mixture of toluene and dichloromethane (1:1) as the optimal solvent pair. This solvent combination, along with the more reliable source of Lewis acid, provided more reproducible results and consistently higher yields (88–96%).
Having identified the critical variables for success of the aldol reaction on one-gram scale we next turned our attention to maximizing material throughput. Increasing reaction concentration and introducing the aldehyde neat, rather than as a solution, did not diminish yield or selectivity. The temperature of aldehyde addition could also be increased from −78 °C to 0 °C, which allowed for shorter reaction times without erosion of diastereoselectivity.19,20
Aware that the solvents and reagents used in both the aldol reaction and hydrolytic removal of the auxiliary were compatible, we contemplated if the two transformations could occur sequentially in a single flask operation. If successful, we would be able to avoid isolation of aldol adduct 4, which required aqueous workup and silica gel chromatography.21 Our initial attempts were plagued by sluggish hydrolysis reactions. We hypothesized that the immiscible solvent combination (PhMe/DCM/H2O) was sequestering lithium peroxide from the substrate. Substituting methanol for aqueous buffer, followed by the addition of a 2:1 THF/H2O2 solution presumably increased the solubility of the nucleophile, thus allowing for a more reasonable hydrolysis rate. The optimized protocol (Scheme 2) provided hydroxy acid (−)-5a directly from propionate 3a as a single isomer by chiral SFC in 96% yield after aqueous workup.22 This one-pot procedure has been successfully utilized on preparative scale to routinely access >90 gram23 batches of either (−)-5a or (+)-5a.
Scheme 2.
One-pot preparation of 1,2-syn-γ-amino acid 5a
We next turned our attention to the preparation of 1,2-anti-γ-amino acids 5b. Many research programs have focused on the anti-aldol reaction.24 Abiko and co-workers had demonstrated that norephedrine propionates 3b could be utilized with dicyclohexylboron triflate to provide 1,2-anti aldol products in good diastereomeric excess and yield. Aspiring towards the goals of high chemical efficiency, selectivity, operational simplicity and maximum material throughput, we initiated our studies with the Abiko protocol.
A survey of various sources of dicyclohexylboron triflate for this aldol reaction revealed the superiority of freshly prepared Lewis acid25 over commercial supplies. The in-house prepared batch of dicyclohexylboron triflate was also less expensive and could be prepared in greater quantities (800 g scale) than was available from commercial vendors.26 Optimization studies focused on the role of solvent used to introduce the Lewis acid. Initially a solution of dicyclohexylboron triflate in hexanes (1 M) was employed as reported by Abiko.24d Further studies revealed dichloromethane as a superior solvent for this reaction (Scheme 3). The anti-aldol reactions performed with a dichloromethane solution (1 M) of dicyclohexylboron triflate were faster, higher yielding, and more consistent. Concerned that this enhanced reactivity of the Lewis acid in dichloromethane would be coupled with instability, we studied the performance of aged solutions (>20 d) in the anti-selective aldol reaction and we were pleased to observe no erosion of yield or diastereoselectivity.
Scheme 3.
Synthesis of 1,2-anti-γ-amino acids 5b.
The hydrolysis of the ephedrine-based auxiliary was initially carried out with lithium hydroxide to provide acid (+)-5b contaminated with its C2-epimer (3–5%). Epimerization was suppressed (<1–2%) by conducting the hydrolysis with sodium hydroxide/hydrogen peroxide in a mixed tert-butanol/methanol solvent system (Scheme 3). Attempts to perform these two transformations sequentially in a single vessel, as was done in the syn-aldol reaction, were unsuccessful. The rate of hydrolysis during these experiments was too slow to be useful. Acceleration of the reaction rate by increasing temperature or changing solvent mixtures was unsuccessful as they were plagued with lower diastereomeric excesses. Fortunately, the two-vessel anti-aldol sequence was reliable and scalable. The chiral hydroxy acids (+)-5b and (−)-5b were obtained as colorless oils without need for silica gel chromatography in >100g quantities per batch.27
Protection of the secondary alcohol as the tert-butyldimethylsilyl ether for downstream applications was the final task of our synthetic sequence (Scheme 4). Preliminary attempts utilized classical conditions involving tert-butyldimethylsilyl chloride and imidazole. These reactions were slow and unreliable on larger scale. A rapid scan of other silylating agents revealed that tert-butyldimethylsilyl triflate28 as a superior reagent. The reaction was allowed to proceed to a bis-silylated species (ester/ether) followed by aqueous workup to remove residual triflic acid. Direct saponification of the silyl ester was accomplished with potassium carbonate in a binary mixture of THF/MeOH to provide amino acids (1a–b) in good yield (83–89%). This procedure is general for all stereoisomers, routinely providing >250 g of product per batch.
Scheme 4.
Synthesis of γ-amino acids 1a–b.
Confident in our ability to rapidly access large quantities of all stereoisomers of γ-amino acid 1, we turned our attention to diversifying the carboxyl terminus. Converting the electrophilic carboxylate to a variety of masked amine or alcohol derivatives expands the utility of the chiral synthon (Scheme 5). Amidation of (+)-1b with methyl amine followed by carbonyl reduction with borane methyl sulfide provided secondary amine 6 in two steps (79% yield). Alternatively, Curtius rearrangement of the acid (−)-1a provided protected amine 7 without stereochemical erosion in 79% yield. Chemoselective reduction of (+)-1a was accomplished via the mixed anhydride to provide the alcohol which was converted to the corresponding tosylate and treated with tetra-n-butylammonium azide to provide compound 8 in 60% overall yield. The alcohol was also esterified with benzoyl chloride and pyridine to provide the orthogonally protected substrate 929 in 70% yield from the acid. Introduction of these chemotypes did not greatly increase molecular weight or require lengthy synthetic sequences thus increasing their utility for downstream activities. The linear templates 6–9 have two stereocenters and three functional groups that are orthogonally protected for rapid access to a variety of chemotypes through appropriate functional group pairing strategies.
Scheme 5.
Preparation of orthogonally protected chiral synthons.
3. Conclusion
The preparation of all possible stereoisomers of a versatile β-hydroxy γ-amino acid has been accomplished by two complementary aldol reactions. A one-pot protocol has been developed to access the 1,2-syn diastereomeric class (1a) in high yield and enantiomeric excess. Significant quantities (>90g) of each stereoisomer have been prepared in single batches. Elaboration of these chiral acids to different orthogonally protected amines could be achieved in short order. The application of these chiral building blocks to a variety of build/couple/pair strategies for DOS has been reported6,30 and is the focus of ongoing work.
4. Experimental Section
4.1. General Procedure
All oxygen and/or moisture-sensitive reactions were carried out under N2 atmosphere in glassware that had been flame-dried under vacuum (~0.5 mmHg) and purged with N2 prior to use. Unless noted otherwise, reagents were introduced into the reaction vessels using syringe and septum techniques under a positive flow of N2 Air- and/or moisture-sensitive solids were transferred in a glove bag. Unless otherwise noted, reactions were stirred with a Teflon™ covered magnet and carried out at room temperature (rt). Concentration refers to the removal of solvent under reduced pressure using a rotary evaporator. Silica gel flash column chromatography was performed using 60 Å (230–400 mesh ASTM) silica gel as the stationary phase on Teledyne ISCO Rf companion purification systems. Cerium ammonium molybdate was used as the primary thin layer chromatography (TLC) staining reagent. 1H-NMR spectra were collected on either a Bruker 300 MHz spectrometer or a Varian Inova 500 MHz spectrometer. All proton chemical shifts are reported in parts per million (ppm) with the solvent reference as the internal standard (CDCl3: δ 7.26 ppm). Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, hex = hextet, m = multiplet, br = broad), coupling constants (Hz), and integration. 13C-NMR (100 MHz) spectra were recorded with complete proton decoupling. Chemical shifts are reported in ppm with the solvent reference as the internal standard (CDCl3: 77.2 ppm). Melting points were reported uncorrected. Compound purity was determined by Waters Acquity HPLC analysis monitored at 210 nm. High resolution exact mass spectrometry was determined by Bruker Daltonics APEXIV 4.7 Tesla Fourier Transform Ion Cyclotron Resonance Mass Spectrometer. Enantiomeric ratios were determined by chiral SFC. Elemental analyses were performed by Robertson Microlit Laboratories, Inc. 29 Samson Ave. Madison, NJ 07940 and are reported in percent abundance.
4.2. Detailed synthetic protocols
4.2.1. tert-Butyl methyl(2-oxoethyl)carbamate (2)
A flame dried 3 L, 3-neck round bottom flask containing a mechanical stirrer (central port), internal temperature probe and addition funnel was charged with oxalyl chloride (176 ml, 2.01 mol) and CH2Cl2 (634 mL). The flask was cooled to −70 °C and DMSO (286 ml, 4.02 mol) was added over 2.5 h at a rate that maintained an internal temperature below −65 °C. The mixture was then stirred for an additional 15 min, after which tert-butyl 2-hydroxyethyl(methyl)carbamate12 (235 g, 1.34 mol) in CH2Cl2 (700 mL) was added over 1 h, followed by slow addition of Et3N (841 ml, 6.04 mol) over 30 min. Both of these reactants were added at a rate that did not cause an increase in internal temperature. After addition of the alcohol solution the reaction was cloudy. Upon initial addition of Et3N the reaction became colorless/clear however at the end the reaction was milky white. The reaction was monitored by TLC (Hex:EtOAc 1:1) until the reaction was deemed complete (2.5 h additional, −70 °C). Saturated aqueous sodium bicarbonate solution (500 mL) was then introduced to quench the reaction at −78 °C. (Note: Quenching is fairly exothermic and thus should be done slowly.) The reaction was warmed to room temperature and the phases were separated. The combined organics were washed with water, dried over MgSO4, and concentrated. (Upon concentration, some small amounts of precipitate (presumably Et3N-HCl salt) were observed however this small amount did not impede distillation or effect final purity.) Distillation (87–89 °C, 3mm Hg) provided aldehyde 2 (200 g, 128 mmol) as a colorless oil, which matched all data reported by Kato and co-workers.12
4.2.2. (2R,3R)-4-(tert-Butoxy-carbonyl(methyl)amino)-3-hydroxy-2-methylbutanoic acid (5a)
A jacketed 5 L, 3-neck round bottom flask was fitted with an overhead mechanical stirrer, internal temperature probe and recirculating chiller. Under a positive flow of N2, the reactor was charged with (R)-4-benzyl-3-propionyloxazolidin-2-one 3a (86.0 g, 367 mmol) followed by CH2Cl2 (835 mL) and toluene (430 mL). The colorless solution was cooled to an internal temperature of −10 °C and degassed with nitrogen for 30 min. Dibutylboron triflate (405 mL, 405 mmol, 1 M in toluene) was added dropwise, maintaining an internal temperature below 0 °C. Next, triethylamine (66.5 mL, 478 mmol) was added dropwise and the resulting enolate solution was stirred at −5 °C for 90 minutes. Afterwards, tert-butyl methyl(2-oxoethyl)carbamate 2 (68.0 mL, 404 mmol) was added dropwise, keeping the internal temperature below 0 °C. Upon complete addition, the light yellow solution was stirred at −5 °C for 90 min. The solution was cooled further to −10 °C and quenched by the slow addition of MeOH (428 mL) followed by a solution of THF:H2O2 (1.23 L, 2:1) that changed the yellow homogenous solution to a biphasic milky-white suspension. (Note: The initial rapid exotherm induced by the peroxide addition can be minimized by initial dropwise addition until no further exotherm is observed.) The reaction was stirred at −10 °C for 90 min at which time both layers became homogeneous. Solid lithium hydroxide (77.0 g, 1.84 mol) was then added to the biphasic mixture and the mixture was allowed to warm to ambient temperature over 12 hours. Excess peroxides were reduced by the careful addition of solid Na2SO3 and organic solvents were removed in vacuo. The slurry was dissolved in dichloromethane and the organic layer was washed with aq. NaOH (1.0 M, 1 L) and brine (100 mL). The aqueous layer was back extracted with CH2Cl2 (2 × 100 mL) to remove the oxazolidinone. The combined aqueous layers were cooled to 0 °C, agitated with a magnetic stir bar and then carefully acidified with concentrated HCl (12 M) to pH 4. The aqueous layer was extracted with EtOAc (3 × 600 mL). The combined organics were dried over MgSO4 and concentrated to provide (2R,3R)-4-(tert-butoxycarbonyl(methyl)amino)-3-hydroxy-2-methylbutanoic acid (−)-5a (74.4 g, 301 mmol, 82% yield) as a colorless oil.31 TLC: Rf = 0.31 (10% MeOH in DCM). [α]D20 −21.6 (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3, 60 °C) δ 4.07 (dt, J = 10, 5 Hz, 1H), 3.41 (br s, 1H), 3.22 (d, J = 15 Hz, 1H), 2.91 (s, 3H), 2.62 (ddd, J = 16, 10, 5 Hz, 1H), 1.45 (s, 9H), 1.25 (d, J = 10 Hz, 3H). 13C NMR (125 MHz, CDCl3, 60 °C) δ 178.0, 80.6, 71.3, 53.1, 43.1, 36.1, 28.6, 11.6. HRMS (ESI) calcd for C11H21NO5Na [M + Na]+: 270.1312. Found: 270.1312.
4.2.3. (2S,3S)-(+)-5a
[α] D20 +16.8 (c 1.0, CHCl3)
4.2.4. 1-Phenyl-2-(N,2,4,6-tetramethylphenylsulfonamido)propyl 4-(tert-butoxycarbonyl(methyl)amino)-3-hydroxy-2-methylbutanoate (4b)
An oven-dried, 3-L, 3-neck round bottom flask was equipped with mechanical stirrer and temperature probe. Under a positive flow of N2, the vessel was charged with (1R,2S)-1-phenyl-2-(N,2,4,6-tetramethylphenylsulfonamido) propyl propionate (109 g, 270 mmol) and CH2Cl2 (932 ml). The reaction was cooled to −78 °C with constant agitation at which point Et3N (112 ml, 810 mmol) was added dropwise (over ~10 minutes), maintaining an internal reaction temperature no greater than −65 °C. After 15 minutes of additional stirring, a solution of dicyclohexylboron triflate (1 M in CH2Cl2, 176 g, 540 mmol) was added dropwise (over ~ 30 minutes), maintaining an internal reaction temperature below −67 °C. The resulting yellow enolate reaction solution was stirred at −78 °C for 2 h additional. At this point tert-butyl methyl(2-oxoethyl)carbamate (68.1 ml, 405 mmol) was added dropwise at a rate so as to maintain an internal temperature below −67 °C (~ 15 minutes). The reaction mixture was stirred at −78 °C for 2 h and then was allowed to warm to 0 °C for 1 h. The reaction was quenched by addition of MeOH (1.09 L) and pH 7 buffer (130 mL). Next aqueous H2O2 (130 ml, 1.5 mol, 35% by wt) was slowly added such that the internal reaction temperature did not exceed 20 °C. After the addition was complete, the mixture was allowed to warm to ambient temperature where it was stirred for 1 h. The resultant slurry was then concentrated in vacuo and the resulting oil was partitioned between water (550 mL) and CH2Cl2 (500 mL). The aqueous layer was extracted with CH2Cl2 (4 × 300 mL) and the combined organic layers were washed with water (100 mL) followed by brine (100 mL). The organic layer was dried over anhydrous MgSO4 and the solvent was removed to yield 1-phenyl-2-(N,2,4,6-tetramethylphenylsulfonamido)propyl 4-(tert-butoxycarbonyl(methyl)amino)-3-hydroxy-2-methylbutanoate as a yellow oil. While the crude product was carried on to the next step without further purification, an analytical sample was obtained by chromatography on silica gel. (S,R,R,S)-(−)-4b: TLC: Rf = 0.34 (30% EtOAc in hexanes). [α]D 20 −10.1 (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3, 60 °C) δ 7.20 (d, J = 7.4 Hz, 2H), 7.05 (d, J = 7.5 Hz, 1H), 6.87 (s, 1H), 5.79 (d, J = 5.3 Hz, 1H), 4.07 (s, 1H), 3.90 (s, 1H), 3.30 (s, 2H), 2.90 (s, 3H), 2.78 (s, 3H), 2.68-2.56 (m, 1H), 2.45 (s, 6H), 2.29 (s, 3H), 1.45 (s, 9H), 1.31 (d, J = 6.8 Hz, 2H), 1.19 (d, J = 7.2 Hz, 1H). 13C NMR (125 MHz, CDCl3, 60 °C) δ 173.8, 142.5, 140.6, 138.3, 132.9, 132.1, 128.6, 128.1, 126.5, 126.3, 80.2, 78.4, 73.1, 58.8, 55.9, 53.3, 47.3, 44.3, 36.3, 35.7, 28.6, 25.7, 24.2, 22.7, 20.9, 13.6, 12.3, 8.9. HRMS (ESI) calcd for C21H30N2O6Na [M + Na]+: 429.1996. Found: 429.2000.
4.2.5 (R,S,S,R)-(+)-4b
[α] D20 +6.42 (c 1.0, CHCl3)
4.2.6. (2R,2S)-4-(tert-Butoxycarbonyl(methyl)amino)-3-hydroxy-2-methylbutanoic acid (5b)
A 3-neck round bottom flask was equipped with an overhead stirrer, an internal temperature probe and an addition funnel. The vessel was charged with the crude 1-phenyl-2-(N,2,4,6-tetramethylphenylsulfonamido)propyl-4-(tert-butoxycarbonyl-(methyl)amino)-3-hydroxy-2-methylbutanoate (202 g, 350 mmol, 1.0 equiv) and 1:1 t-BuOH/MeOH (4.5 L) was added and cooled to 0 °C. A solution of H2O2 (35% in water, 184 ml, 2101 mmol, 6.0 equiv) was added via addition funnel, followed by aqueous NaOH (1.0 M, 1051 ml, 1051 mmol, 3.0 equiv), which was added at such a rate that the internal temperature did not rise above 10 °C. The mixture was warmed to rt slowly and allowed to stir overnight. Additional H2O2 (40 mL) and aq. NaOH (200 mL) solutions were added at 0 °C to drive the reaction to completion and the organic solvents were then removed in vacuo. The resulting aqueous layer was diluted with water (500 mL) and extracted with EtOAc (4 × 400 mL) to remove the auxiliary. The resulting aqueous layer was then acidified with 6 M HCl to pH 4 and extracted with EtOAc (5 × 500 mL). This second set of EtOAc extracts were combined, dried (MgSO4), filtered and concentrated. While the crude product was carried on to the next step without further purification, an analytical sample was obtained by chromatography on silica gel. (2R,3S)-(+)-5b: [α]D20 +2.1 (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3, 60 °C) δ 3.99 (s, 1H), 3.91 (dd, J = 5.7, 11.4 Hz, 1H), 3.39 (m, 1H), 2.95 (s, 0.5 × 3H), 2.93 (s, 0.5 × 3H), 2.59 (dd, J = 6.2, 12.0 Hz, 1H), 1.48 (s, 0.5 × 9H), 1.47 (s, 0.5 × 9H), 1.28 (d, J = 7.2 Hz, 3H). 13C NMR (125 MHz, CDCl3, 60 °C) δ 181.1, 158.2, 81.0, 72.6, 53.4, 43.8, 36.2, 28.7, 15.0. HRMS (ESI) calcd for C11H21NO5Na [M + Na]+: 270.1312. Found: 270.1312.
4.2.7. (2S,3R)-(−)-5b
[α]D20 −1.9 (c 1.0, CHCl3).
4.2.8. General reaction protocol for TBS protection. 4-(tert-butoxycarbonyl(methyl)amino)-3-(tert-butyldimethylsilyloxy)-2-methyl butanoic acid (1a)
An oven dried, 5 L 3-neck round bottom flask equipped with magnetic stirrer and internal temperature probe was charged with 4-(tert-butoxycarbonyl(methyl)amino)-3-hydroxy-2-methylbutanoic acid 5a (1.0 equiv), CH2Cl2 (concentration of 5a = 0.1 M) and 2,6-lutidine (3.0–5.0 equiv) under a positive flow of N2. The reaction mixture was cooled to −78 °C and tert-butyldimethylsilyl trifluoromethanesulfonate (TBSOTf) (2.2–3.0 equiv) was added dropwise over 20 min. The reaction mixture was stirred at −78 °C for 1 h, quenched with aqueous sat. NaHCO3, the layers were separated, and the aqueous layer was extracted with Et2O. The combined organic extracts were washed with aqueous sat. NH4Cl and brine, dried (MgSO4), filtered and the solvent evaporated. The residue was dissolved in MeOH and THF and cooled to 0 °C. An aqueous solution of K2CO3 (1.5–2.2 equiv) was added and the mixture was stirred at 0 °C for 1 h. The reaction mixture was concentrated to remove volatile solvents and the remaining aqueous layer was extracted with EtOAc. The organic layer was washed with 1 N HCl, then dried over MgSO4, filtered and concentrated in vacuo to yield the crude product as a clear oil which was co-evaporated with toluene to remove excess TBSOH and dried to provide the product 1a as a clear oil.
Following the general reaction protocol (2R,3R)-5a (180 g, 728 mmol, 1.0 equiv) was reacted with TBSOTf (502 mL, 2.18 mol, 3.0 equiv) and 2,6-lutidine (424 mL, 3.64 mol, 5.0 equiv) in CH2Cl2 (3.5 L), and worked up with aqueous K2CO3 (151 g in 750 mL, 1090 mmol, 1.5 equiv) and MeOH (1475 mL) in THF (1475 mL) to provide pure product (2R,3R)-1a (260 g, 99%) as a clear oil. (2R,3R)-(−)-1a: TLC: Rf = 0.70 (33% EtOAc in hexanes). [α]D20 −29.1 (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3, 60 °C) δ 4.32-4.22 (m, 1H), 3.55-3.33 (m, 1H), 3.09 (dd, J = 6.7, 14.2 Hz, 1H), 2.89 (s, 3H), 2.69-2.41 (m, 1H), 1.47 (s, 9H), 1.23 (d, J = 7.1 Hz, 3H), 0.90 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H). 13C NMR (125 MHz, CDCl3, 60 °C) δ 179.3, 156.1, 80.2, 71.6, 53.0, 43.3, 36.4, 26.1, 18.2, 10.8, −4.30, −4.63. HRMS (ESI) calcd for C17H25NO5Si Na [M + Na]+: 384.2177. Found: 384.2173.
4.2.9. (2S,3S)-(+)-1a
[α] D20 +23.3 (c 0.9, CHCl3).
4.2.10
Following the general reaction protocol (2R,3S)-5b (58.7 g, 237 mmol, 1.0 equiv) was reacted with TBSOTf (120 mL, 522 mmol, 2.2 equiv) and 2,6-lutidine (91 mL, 783 mmol, 3.3 equiv) in CH2Cl2 (950 mL), and worked up with aqueous K2CO3 (1.6 M, 325 mL, 522 mmol, 2.2 equiv) and MeOH (500 mL) in THF (500 mL) to provide pure product (R,S)-1b (74.1 g, 83%) as a colorless oil. (2R,3S)-(−)-1b: TLC: Rf = 0.67 (33% EtOAc in hexanes). [α]D20 −3.2 (c 0.6, CHCl3). 1H NMR (500 MHz, CDCl3, 60 °C) δ 4.17 (br s, 1H), 3.35 (dd, J = 14.5, 6.0 Hz, 1H), 3.25 (br s, 1H), 2.90 (s, 3H), 2.66 (br s, 1H), 1.46 (s, 9H), 1.22 (d, J = 7.0 Hz, 1H), 0.91 (s, 9H), 0.11 (s, 3H), 0.10 (s, 3H). 13C NMR (125 MHz, CDCl3, 60 °C) δ 176.8, 156.4, 80.3, 72.4, 52.9, 43.9, 36.7, 28.7, 26.0, 18.2, 12.8, −4.2, −4.7. HRMS (ESI) calcd for C17H25NO5SiNa [M + Na]+: 384.2177. Found: 384.2167.
4.2.11. (2S,3R)-(+)-1b
[α]D20 +3.7 (c 1.0, CHCl3).
4.2.12. tert-Butyl (2R,3R)-2-(tert-butyldimethylsilyl)oxy-3-methyl-4-(methylamino)-butyl)(methyl)carbamate (6)
To a solution of (−)-(2R,3R)-4-(tert-butoxycarbonyl(methyl)amino)-3-(tert-butyldimethylsilyloxy)-2-methyl butanoic acid (−)-1a (4.49 g, 12.4 mmol) and DIEA (6.5 mL, 37 mmol, 3.0 equiv.) in CH2Cl2 (96 mL) was added methylamine (7.45 mL, 14.9 mmol, 1.2 equiv.). PyBop (6.46 g, 12.4 mmol, 1.0 equiv.) was added at once and the mixture was stirred overnight. The reaction mixture was diluted with CH2Cl2 and sat. aq. NH4Cl, the phases separated, and the organic phase was dried (MgSO4), filtered and concentrated. Purification was accomplished via silica gel chromatography to yield 11.7 g (94%) of tert-butyl (2R,3S)-2-(tert-butyldimethylsilyl)oxy-3-methyl-4-(methylamino)-4-oxobutyl)(methyl)carbamate S1 as an oil. 1H NMR (500 MHz, CDCl3, 50 °C) δ 6.69 (s, 0.5 × 1H), 6.38 (s, 0.5 × 1H), 4.01 (br s, 1H), 3.32 (dd, J = 6.5, 14.2 Hz, 1H), 3.20 (dd, J = 6.1, 14.1 Hz, 1H), 2.88 (s, 3H), 2.78 (d, J = 4.8 Hz, 3H), 2.41 (qd, J = 3.5, 7.2 Hz, 1H), 1.46 (s, 9H), 1.21 (d, J = 7.3 Hz, 3H), 0.92 (s, 9H), 0.12 (s, 3H), 0.11 (s, 3H). 13C NMR (125 MHz, CDCl3, 50 °C) δ 174.7, 138.0, 80.0, 72.8, 53.7, 45.0, 36.8, 28.7, 26.2, 21.6, 18.2, 15.6, −4.1, −4.6.
To a chilled (0 °C) solution of amide S1 (4.37 g, 11.7 mmol) in THF (100 mL) was added dropwise BH3-SMe2 (5.5 mL, 58.3 mmol, 5 equiv.). The reaction mixture was warmed to rt then the flask was fitted with a reflux condenser and the reaction mixture was heated in a 65 °C oil bath for 24 h. The mixture was cooled in an ice bath and quenched with MeOH. The mixture was concentrated, the residue was dissolved in MeOH (80 mL) and a saturated aq. solution of Rochelle’s salt (50 mL) was added. The mixture was heated in a 90 °C oil bath for 48 h, then cooled to rt and concentrated. The residue was diluted with EtOAc and water, the aqueous phase extracted with EtOAc and the combined organics were washed with brine, dried (MgSO4) and the solvent evaporated to yield tert-butyl (2R,3R)-2-(tert-butyldimethylsilyl)oxy-3-methyl-4-(methylamino)-butyl)(methyl)carbamate (6) as a colorless oil (3.55 g, 84%) 1H NMR (500 MHz, DMSO, 120 °C) δ 3.97 (dt, J = 3.9, 7.7 Hz, 1H), 3.28 (dd, J = 4.4, 14.1 Hz, 1H), 3.10 (dd, J = 7.8, 14.1 Hz, 1H), 2.84 (s, 3H), 2.64 (dd, J = 5.4, 11.9 Hz, 1H), 2.41 (dd, J = 7.9, 11.9 Hz, 1H), 2.36 (s, 3H), 1.89-1.78 (m, 1H), 1.43 (s, 9H), 0.94 (d, J = 6.9 Hz, 3H), 0.91 (s, 9H), 0.08 (s, 3H), 0.06 (s, 3H). 13C NMR (125 MHz, CDCl3, 60 °C) δ 156.4, 73.8, 72.9, 54.9, 54.0, 52.1, 37.0, 28.7, 26.1, 18.2, 14.6, 13.9, −4.4. HRMS (ESI) calcd for C18H40N2O3Si [M + H]+: 361.2886. Found: 361.2888.
4.2.13. tert-Butyl ((2S,3R)-3-((benzyloxy)carbonyl)amino-2-(tert-butyldimethylsilyl)oxy-butyl)(methyl)carbamate (7)
To a solution of 4-(tert-butoxycarbonyl(methyl)amino)-3-(tert-butyldimethylsilyloxy)-2-methyl butanoic acid (+)-1a (1.15 g, 3.18 mmol) in toluene (32 mL) was added Et3N (0.62 mL, 4.5 mmol) and DPPA (0.83 mL, 3.8 mmol). The mixture was heated to 60 °C for 3 h, then benzyl alcohol (1.65 mL, 15.9 mmol) was added and the mixture heated to reflux overnight. The mixture was cooled and concentrated and the residue diluted with EtOAc, washed with H2O, dried (MgSO4) and the solvent evaporated. Purification was accomplished with chromatography on silica gel to provide tert-butyl ((2S,3R)-3-((benzyloxy)carbonyl)amino-2-(tert-butyldimethylsilyl)oxy-butyl)(methyl)carbamate (7) as a clear resin (1.18 g, 79%). [α]D20 +4.4 (c 1.0, CHCl3). 1H NMR (500 MHz, DMSO) δ 7.38-7.28 (m, 5H), 6.24 (br s, 1H), 5.17-4.92 (m, 2H), 4.02 (br s, 1H), 3.61 (br s, 1H), 3.33 (dd, J = 5.9, 14.3 Hz, 1H), 3.08 (dd, J = 7.0, 14.0 Hz, 1H), 2.83 (s, 3H), 1.43 (s, 9H), 1.08 (d, J = 6.6 Hz, 3H), 0.90 (s, 9H), 0.06 (s, 3H), 0.04 (s, 3H). 13C NMR (126 MHz, DMSO) δ 154.7, 154.4, 136.7, 127.4, 127.0, 126.8, 78.1, 71.7, 64.7, 49.0, 34.6, 27.5, 25.2, 17.0, 13.6, −5.4. HRMS (ESI) calcd for C17H35NO5SiNa [M + Na]+: 489.2761. Found: 489.2753.
4.2.14. tert-Butyl-((2S,3R)-4-azido-2-((tert-butyldimethylsilyl)oxy)-3-methylbutyl)(methyl)carbamate (8)
To a solution of 1a (500 mg, 1.25 mmol) in dry THF (14 mL) under N2 and chilled to 0 °C was added Et3N (0.23 mL, 1.7 mmol) followed by isobutyl chloroformate (0.16 mL, 1.7 mmol). The resultant suspension was stirred at ambient temperature for 2 h, then cooled to 0 °C and a solution of NaBH4 (314 mg, 8.30 mmol) in water (6 mL) was added dropwise. The mixture was stirred for 2 h, warming slowly to ambient temperature. The reaction mixture was then diluted with water and the aqueous phase was extracted with EtOAc. The combined organic phases were washed with water, brine, dried (Na2SO4) and the solvent was evaporated. To a solution of this alcohol (362 mg, 1.04 mmol) in dry CH2Cl2 (10 mL) under N2 and chilled to 0 °C was added p-toluenesulfonyl chloride (218 mg, 1.15 mmol) followed by Et3N (0.44 mL, 3.1 mmol) then DMAP (13 mg, 0.10 mmol). The reaction mixture was stirred for 16 h then was quenched with water, the phases separated and the aqueous phase was washed with CH2Cl2. The combined organic phases were washed with sat. aq. NaHCO3 (2x), then sat. aq. NH4Cl (2x), water, brine, dried (Na2SO4) and the solvent evaporated to provide S2, which was carried on to the next step without further purification.
Tetrabutylammonium azide (567 mg, 1.99 mmol) was added to a solution of tosylate S2 (500 mg, 0.997 mmol) in dry DMF (10 mL) under nitrogen. The reaction mixture was stirred until LCMS indicated the disappearance of starting material. The reaction mixture was diluted with water and EtOAc and the phases separated. The aqueous phase was washed with EtOAc and the combined organics were washed with water and brine, dried (Na2SO4) and the solvent evaporated. Purification was accomplished via silica gel chromatography (EtOAc/hexanes) to yield tert-Butyl-((2S,3R)-4-azido-2-((tert-butyldimethylsilyl)oxy)-3-methylbutyl)(methyl)carbamate (8) as a colorless oil (224 mg, 0.601 mmol, 60% yield). [α]D20 +15.5 (c 1.0, CHCl3). 1H NMR (500 MHz, DMSO, 80 °C) δ 3.99 (t, J = 5.2 Hz, 1H), 3.42-3.17 (m, 3H), 3.06 (dd, J = 6.1, 13.8 Hz, 1H), 2.82 (s, 3H), 1.78 (dd, J = 6.6, 11.9 Hz, 1H), 1.42 (s, 9H), 0.92 (d, J = 6.9 Hz, 3H), 0.89 (s, 9H), 0.10 (s, 3H), 0.08 (s, 3H). 13C NMR (126 MHz, DMSO) δ 154.4, 78.3, 69.8, 53.3, 51.2, 35.8, 35.1, 27.7, 25.3, 17.2, 11.0, −4.9, −5.4. HRMS (ESI) calcd for C17H36N4O3SiNa [M + Na]+: 373.2635. Found: 373.2631.
4.2.15. (2S,3S)-4-((tert-Butoxycarbonyl)(methyl)amino)-3-((tert-butyldimethylsilyl)oxy)-2-methylbutyl benzoate (9)
To a solution of acid 1b (1.42 g, 3.93 mmol) in dry THF (20 mL) under N2 was added Et3N (1.1 mL, 7.9 mmol) at 0 °C followed by isobutyl chloroformate (0.668 mL, 5.11 mmol). The resultant suspension was stirred at rt for 2 h and then chilled to 0 °C. A solution of NaBH4 (892 mg, 23.6 mmol) in H2O (17 mL) was added dropwise and the mixture was stirred for 2 h, warming slowly to rt. The reaction mixture was then diluted with H2O and the aqueous phase was extracted with EtOAc. The combined organic phases were washed with H2O, brine, dried (Na2SO4) and the solvent was evaporated to yield S3, which was carried on crude to provide benzoate 9.
To a solution of crude alcohol S3 in dry CH2Cl2 (20 mL) under N2 was added pyridine (6.4 mL) then benzoyl chloride (2.3 mL, 20 mmol). The reaction mixture was stirred overnight (16 h) then diluted with CH2Cl2 and 0.1 N HCl. The phases were separated and the aqueous was washed with CH2Cl2. The combined organics were washed with 0.1 N HCl, H2O, brine, dried (Na2SO4) and the solvent evaporated. Purification was accomplished via silical gel chromatography (EtOAc/hexanes) to yield (2S,3S)-4-((tert-butoxycarbonyl)(methyl)amino)-3-((tert-butyldimethylsilyl)oxy)-2-methylbutyl benzoate (9) (1.24 g, 70%) as a colorless oil. [α]D20 + 5.6 (c 1.0, CHCl3). 1H NMR (500 MHz, DMSO, 80 °C) δ 7.97 (d, J = 7.5 Hz, 2H), 7.63 (t, J = 7.2 Hz, 1H), 7.50 (t, J = 7.5 Hz, 2H), 4.24 (d, J = 6.9 Hz, 2H), 4.15 (t, J = 6.0 Hz, 1H), 3.36 (dd, J = 6.4, 14.0 Hz, 1H), 3.19 (dd, J = 6.5, 14.0 Hz, 1H), 2.85 (s, 3H), 2.08 (dd, J = 6.7, 13.0 Hz, 1H), 1.41 (s, 9H), 1.00 (d, J = 6.9 Hz, 3H), 0.92 (s, 9H), 0.09 (s, 6H). 13C NMR (126 MHz, DMSO, 80 °C) δ 165.2, 154.5, 132.7, 129.6, 128.5, 128.2, 78.3, 69.2, 65.8, 51.4, 35.1, 27.7, 25.3, 18.4, 17.3, 9.8, −4.9, −5.5. HRMS (ESI) calcd for C24H41NO5SiNa [M + Na]+: 474.2652. Found: 474.2652.
Supplementary Material
Acknowledgments
This work was funded in part by the NIGMS-sponsored Center of Excellence in Chemical Methodology and Library Development (Broad Institute CMLD; P50 GM069721), as well as the NIH Genomics Based Drug Discovery U54 grants Discovery Pipeline RL1CA133834 (administratively linked to NIH grants RL1HG004671, RL1GM084437, and UL1RR024924).
Footnotes
Supplementary data associated with this article can be found in the online version.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References and Notes
- 1.Castejón P, Moyano A, Pericàs MA, Riera A. Tetrahedron. 1996;52:7063–7086. [Google Scholar]
- 2.(a) Umezawa H, Aoyagi T, Marishima H, Matsuzaki M, Hamada M, Takeuchi T. J Antibiot. 1970;23:259–262. doi: 10.7164/antibiotics.23.259. [DOI] [PubMed] [Google Scholar]; (b) Pesenti C, Arnone A, Bellosta S, Bravo P, Canavesi M, Corradi E, Frigerio M, Meille SV, Monetti M, Panzeri W, Viani F, Venturini R, Zanda M. Tetrahedron. 2001;57:6511–6522. [Google Scholar]; (c) Pesenti C, Arnone A, Aubertin AM, Bravo P, Frigerio M, Panzeri W, Schmidt S, Viani F, Zanda M. Tetrahedron Lett. 2000;41:7239–7243. [Google Scholar]
- 3.(a) Rizvi SA, Tereshko V, Kossiakoff AA, Kozmin SA. J Am Chem Soc. 2006;128:3882–3883. doi: 10.1021/ja058319c. [DOI] [PubMed] [Google Scholar]; (b) Wrona IE, Lowe JT, Turbyville TJ, Johnson TR, Beignet J, Beutler JA, Panek JS. J Org Chem. 2009;74:1897–1916. doi: 10.1021/jo802269q. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Dai CF, Cheng F, Xu HC, Ruan YP, Huang PQ. J Comb Chem. 2007;9:386–394. doi: 10.1021/cc060166h.and references sited therein.
- 5.(a) Li W-R, Joullié MM. Studies in Natural Products Chemistry. In: Attaur-Rahman, editor. Stereoselective Synthesis (Part F) Vol. 10. Elsevier; Amsterdam: 1992. pp. 241–302. [Google Scholar]; (b) Wipf P. Chem Rev. 1995;95:2115–2134. [Google Scholar]
- 6.Marcaurelle LA, Comer E, Dandapani S, Duvall JR, Gerard B, Kesavan S, Lee MD, IV, Liu H, Lowe JT, Marie JC, Mulrooney CA, Pandya BA, Rowley A, Ryba TD, Suh BC, Wei J, Young DW, Akella LB, Ross NT, Zhang YL, Fass DM, Reis SA, Zhao WZ, Haggarty SJ, Palmer M, Foley MA. J Am Chem Soc. 2010;132:16962–16976. doi: 10.1021/ja105119r. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.(a) Neilson TE, Schreiber SL. Angew Chem Int Ed. 2007;74:48–56. [Google Scholar]; (b) Uchida T, Rodriguez M, Schreiber SL. Org Lett. 2009;11:1559–1562. doi: 10.1021/ol900173t. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Schreiber SL. Nature. 2009;457:153–154. doi: 10.1038/457153a. [DOI] [PubMed] [Google Scholar]; (d) Pizzirani D, Kaya T, Clemons P, Schreiber SL. Org Lett. 2010;12:2822–2825. doi: 10.1021/ol100914b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.For reviews on recent developments on the aldol reaction, see Schetter B, Mahrwald R. Angew Chem Intl Ed. 2006;45:7506–7525. doi: 10.1002/anie.200602780.Palamo C, Oiarbide M, Garcia JM. Chem Soc Rev. 2004;33:65–75. doi: 10.1039/b202901d.Machajewski TD, Wong CH. Angew Chem Intl Ed. 2000;39:1352–1374. doi: 10.1002/(sici)1521-3773(20000417)39:8<1352::aid-anie1352>3.0.co;2-j.Mahrwald R. Chem Rev. 1999;99:1095–1120. doi: 10.1021/cr980415r.
- 9.Ordonez M, Cativiela C. Tetrahedron: Asymmetry. 2007;18:3–99. doi: 10.1016/j.tetasy.2009.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Evans DA. Aldrichimica Acta. 1982;15:23–32.and references therein Evans D, Nelson JV, Vogel E, Taber TR. J Am Chem Soc. 1981;103:3099–3111.Evans DA, Bartroli J, Shih TL. J Am Chem Soc. 1981;103:2127–2129.Evans DA, Dart MJ, Duffy JL, Reiger DL. J Am Chem Soc. 1995;117:9073–9074.Evans DA, Ratz AM, Huff BE, Sheppard GS. J Am Chem Soc. 1995;117:3448–3467.Sasmal S, Geyer A, Maier ME. J Org Chem. 2002;67:6260–6263. doi: 10.1021/jo025889b.
- 11.Inoue T, Liu JF, Buske DC, Abiko A. J Org Chem. 2002;67:5250–5256. doi: 10.1021/jo0257896. [DOI] [PubMed] [Google Scholar]
- 12.Kato S, Harada H, Morie TM. J Chem Soc, Perkin Trans. 1997;1:3219–3225. [Google Scholar]
- 13.(a) Mancuso AJ, Swern D. Synthesis. 1981:165–185. [Google Scholar]; (b) Tidwell TT. Synthesis. 1990:857–869. [Google Scholar]
- 14.Based on Aldrich prices for reagents.
- 15.Gage JR, Evans DA. Org Synth Coll. 1993;8:339–344. [Google Scholar]
- 16.Mickel SJ, Sedelmeier GH, Niederer D, Daeffler R, Osmani A, Schreiner K, Seeger-Weibel M, Berod B, Gamboni R. Org Process Res Dev. 2004;8:92–100. [Google Scholar]
- 17.Available from BASF.
- 18.The solutions were stored on the bench in air-free containers without appreciable change in concentration over 30 days. Molarity was assessed by No-D 1H NMR (Hoye T, Eklov BM, Ryba TD, Voloshin M, Yao LJ. Org Lett. 2004;6:953–956. doi: 10.1021/ol049979+.
- 19.No epimerization was detected by chiral SFC analysis of an aldol reaction that was warmed to room temperature for 18 hours then subjected to the hydrolysis conditions.
- 20.At −78 °C we observed freezing of the aldehyde upon contact with the solution. In contrast, when the addition is carried out at 0 °C, the aldehyde quickly dissolves with the aid of vigorous stirring.
- 21.After aqueous workup the aldol adduct (−)-4a was isolated as a colorless oil (>95% by HPLC), which could be carried forward to the subsequent hydrolysis. Alternatively, silica gel chromatography provided the adduct as a white solid from which we obtained single crystals for x-ray analysis. CCDC 828856 contains the supplementary crystallographic data for (−)-4a. This data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
- 22.Absolute stereochemical assignment for (+)-5a was confirmed by x-ray crystallography. Purity was >95% by HPLC and e.r. 99:1 by SFC. CCDC 828857 contains the supplementary crystallographic data for (+)-5a. This data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
- 23.The total volume of the reaction after the addition of all reagents and solvents dictated the scale of the reaction. In house capabilities were initially limited to a 5-L jacketed round bottom flask. We have since transferred this protocol to a contract research organization where it has been routinely performed on >500g scale.
- 24.(a) Corey EJ, Kim SS. J Am Chem Soc. 1990;112:4976–4977. [Google Scholar]; (b) Brown HC, Ganesan K. Tetrahedron Lett. 1982;33:3421–3424. [Google Scholar]; (c) Ganesan K, Brown HC. J Org Chem. 1992;59:2336–2340. [Google Scholar]; (d) Abiko A, Liu JF, Masamune S. J Org Chem. 1996;61:2590–2591. doi: 10.1021/jo960252b. [DOI] [PubMed] [Google Scholar]; (d) Abiko A, Liu JF, Masamune S. J Am Chem Soc. 1997;119:2586–2587. [Google Scholar]
- 25.Abiko A. Organic Syntheses Coll. 2004;10:273–276. [Google Scholar]
- 26.Synthesis of 0.8 kilogram batches of the Lewis acid required scrupulously air-free conditions as noted in reference 16.
- 27.Absolute stereochemical assignment for (−)-5b was confirmed by conversion to the corresponding Mosher ester.
- 28.Corey EJ, Cho H, Rucker C, Hua DH. Tetrahedron Lett. 1981;22:3455–3458. (b) The reagent was prepared in 0.5 kilogram batches according to the Corey protocol.
- 29.We performed the selective deprotection of the silyl ether by means of TBAF, while the benzoate is hydrolyzed by K2CO3/MeOH, and the selective deprotection of the Boc group is accomplished by treatment with TBSOTf followed by p-TsOH in DCM.
- 30.(a) Comer E, Liu H, Joliton A, Clabaut A, Johnson C, Akella LB, Marcaurelle LA. Proc Natl Acad Sci USA. 2011;108:6751–6756. doi: 10.1073/pnas.1015255108. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Gerard B, Duvall JR, Lowe JT, Murillo T, Wei J, Akella LB, Marcaurelle LA. ACS Comb Sci. 2011 doi: 10.1021/co2000218. ASAP. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Borane impurities, presumably from incomplete hydrolysis, have been observed in large batches. They have been removed by trituration with cold CH2Cl2. Typically the oil after workup is dissolved in CH2Cl2 (0.5 L) and stored in a −20 °C fridge. After 12 h at this temperature white precipitate was observed and was removed from the sample by cold filtration. The sample was concentrated and analyzed by 1H NMR. If necessary, the process was repeated.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.







